|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.22 CNY | -0.08% |
|
+0.69% | -9.83% |
| Jul. 07 | Jumpcan Gets Approval for Traditional Chinese Drug for Constipation, Stomach Strengthening | MT |
| Jun. 16 | Jumpcan Pharmaceutical Receives Tender Offer Worth 9.45 Billion Yuan | MT |
| Capitalization | 24.17B 3.37B 2.88B 2.69B 2.5B 4.61B 289B 5.13B 32.17B 12.3B 135B 12.64B 12.38B 497B | P/E ratio 2025 * |
11.2x | P/E ratio 2026 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise value | 24.17B 3.37B 2.88B 2.69B 2.5B 4.61B 289B 5.13B 32.17B 12.3B 135B 12.64B 12.38B 497B | EV / Sales 2025 * |
3.33x | EV / Sales 2026 * | 3.11x |
| Free-Float |
37.52% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
| 1 day | -0.08% | ||
| 1 week | +0.69% | ||
| Current month | -0.42% | ||
| 1 month | -4.69% | ||
| 3 months | -3.28% | ||
| 6 months | -5.48% | ||
| Current year | -9.83% |
| 1 week | 25.77 |  | 26.46 |
| 1 month | 25.76 | | 29.3 |
| Current year | 25 | | 30.39 |
| 1 year | 23.85 | | 34.46 |
| 3 years | 21.23 | | 45.18 |
| 5 years | 14.37 | | 45.18 |
| 10 years | 14.37 | | 54.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Cao
CEO | Chief Executive Officer | 42 | 2019-12-19 |
Hong Cun Yan
DFI | Director of Finance/CFO | 57 | 2022-09-25 |
Wei Cao
SEC | Corporate Secretary | 39 | 2018-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qu Rong Huang
BRD | Director/Board Member | 63 | 2014-03-09 |
Fei Cao
BRD | Director/Board Member | 42 | 2014-03-09 |
Xin Chun Zhou
CHM | Chairman | 56 | 2023-05-07 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.42% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.08% | +0.69% | -17.57% | +5.34% | 3.37B | ||
| +0.60% | -1.19% | -9.23% | +34.66% | 4.53B | ||
| +0.07% | -0.53% | -4.48% | -42.94% | 3.48B | ||
| -0.25% | -0.50% | +22.87% | +52.26% | 3.3B | ||
| +0.73% | +2.28% | +3.01% | +38.94% | 3.12B | ||
| +0.42% | +1.56% | +8.83% | -13.21% | 2.49B | ||
| +1.67% | -0.68% | +25.58% | +92.35% | 1.82B | ||
| -0.26% | -2.64% | -3.94% | +92.44% | 1.8B | ||
| -0.25% | +0.25% | +25.95% | -43.63% | 1.67B | ||
| +0.09% | -1.23% | +16.18% | -12.98% | 1.66B | ||
| Average | +0.27% | +0.39% | +6.72% | +20.32% | 2.72B | |
| Weighted average by Cap. | +0.28% | +0.47% | +3.67% | +19.35% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 7.25B 1.01B 864M 805M 749M 1.38B 86.74B 1.54B 9.65B 3.69B 40.61B 3.79B 3.71B 149B | 7.78B 1.09B 928M 865M 804M 1.49B 93.13B 1.65B 10.36B 3.96B 43.61B 4.07B 3.99B 160B |
| Net income | 2.16B 301M 258M 240M 223M 412M 25.85B 458M 2.88B 1.1B 12.11B 1.13B 1.11B 44.4B | 2.4B 335M 286M 267M 248M 458M 28.73B 509M 3.2B 1.22B 13.45B 1.26B 1.23B 49.34B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
5,026
Sector
Pharmaceuticals
Calendar
Aug. 22
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 26.22 ¥ | -0.08% | 5,494,387 |
| 25-07-10 | 26.24 ¥ | +0.92% | 8,179,133 |
| 25-07-09 | 26.00 ¥ | +0.50% | 4,733,294 |
| 25-07-08 | 25.87 ¥ | +0.15% | 3,959,370 |
| 25-07-07 | 25.83 ¥ | -0.81% | 4,634,585 |
End-of-day quote Shanghai S.E., July 10, 2025
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
26.22
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600566 Stock
Select your edition
All financial news and data tailored to specific country editions
